As Seen on NBC Nightly News With Lester Holt
Our Breakthrough Technology Focuses on the Tongue
Our patented Tongue Elastic is the key to ending your snoring. Our mouthpiece is similar to other snoring aids by advancing the jaw forward, but by adding something of a seatbelt in the back, we've created a way to keep the tongue in place. This prevents the tongue from blocking airways and keeps air passages open at night. The guard is form fitted to your teeth, comfortable enough that our users report no major adjustments needed for a normal night of sleep.
Don't Just Take Our Word For It
Our customers have left 338 reviews on our website. So far, they're all 4- and 5-stars, including 244 5-star reviews.
Our Progress So Far
Research and Development of 1st generation Oral Appliance
Dr. Greenburg also expands from 1 snoring and sleep apnea treatment center to 5 and received FDA 510k clearance for the first hybrid oral appliance.
Sales exceed $300k/year
We also launched ZYPPAH Professional.
Media Partnership with Sirius Radio Stars, Dr. Laura and Jenny McCarthy
Plus, sales exceed $3M/year.
Clinical Trial for Effectiveness of Zyppah Device
We also launch a billboard in Times Square, sponsor the #7 Indycar at the Indianapolis 500, release a glow in the dark ZYPPAH, and see sales top $13M/year.
Let's Eliminate Snoring Together
I’m Dr. Jonathan Greenburg. As a dentist for twenty years, and now as the founder CEO of ZYPPAH, I've spent my life helping patients live better. ZYPPAH is a high-growth developer of Hybrid Oral Appliances invented to solve the problem of snoring and sleep apnea. ZYPPAH, which is “Happy Z” spelled backward, in a phrase, embodies my passion to realize a world where Happy Z’s become the norm for every individual around the world.
Sleep is an essential element of one’s overall health and well-being, but in the United States alone, it is estimated that some 90 million adults snore. Globally, it's estimated at 500 million. While some might feel that snoring is just a nuisance and something to be ignored, snoring is often a warning sign of a more dangerous condition - sleep apnea. The consequences of untreated snoring and undiagnosed sleep apnea can be severe. It is estimated that up to 75% of strokes, heart attacks, diabetes, and high blood pressure patients have an underlying sleep apnea condition.
Since launching in 2015, ZYPPAH has sold over 200,000 units and generated $24,000,000 in cumulative sales. As you review our campaign, you will learn how ZYPPAH’s solution is one of a kind. You will see testimonials of lives transformed because of ZYPPAH, and comparisons in the media that show ZYPPAH as the only solution that works.
ZYPPAH is a profitable business. We’ve invested 100% of our profits back into the company to help us become a global brand and industry leader. Our company has two primary business units. Our consumer unit is focused on direct sales of snoring devices to the public, while our professional unit focuses on treating patients with sleep apnea.
According to research by Micromarket Monitor, the global sleep apnea devices market is expected to reach $27.4B by 2020. Frost and Sullivan predict that the US Oral Appliances market will double between 2015-2020, with custom appliances growing by 500% over the same period.
Now, we’re initiating a fundraising campaign to accelerate our growth worldwide to seize this vast opportunity. We’re raising funds to expand into retail stores, acquire inventory for international distribution, and grow our professional division focusing on the treatment of sleep apnea patients.
Our team has the passion, vision, and experience to achieve the ambitious goals we’ve set in 2018 and beyond. We invite you to be a part of the next exciting phase of our growth.
Dr. Jonathan Greenburg, Founder and CEO